Accurate molecular structure and chirality information is foundational in drug activity, safety, and manufacturability. Traditional analytical tools often lack the sensitivity or specificity needed for modern drug candidates and complex chemical products — slowing programs and increasing costs. Enantios ROA fills this gap with direct structural insight that supports critical decisions in R&D and production.
Advanced Molecular Insight for Pharma & Chemical Innovation
We enable direct, in-solution, actionable structural and chiral analysis of complex molecules and biologics using advanced Raman Optical Activity (ROA) instrumentation.
Accelerate Discovery. Reduce Risk. Improve Quality.
No chiral separation required
Analyze samples without time-consuming HPLC workflows.
No crystallization needed
Work directly with in-solution samples.
Lab-ready design
Compact, robust instrument built for real laboratory environments.
No experimental reference standards
Reduce dependency on costly or unavailable standards.
Instruments & Measurement Services
Expert Measurement Services
Not ready to invest in instrumentation? Benefit from Enantios’ measurement services — from proof-of-concept studies to detailed molecule analysis — tailored to your R&D or quality challenge.
ROA Instruments Built for Industry
Our ROA instruments are engineered for reproducibility, stability, and ease of use in pharmaceutical and chemical labs — letting your team focus on interpretation and decisions, not laser alignment or specialized optics.
Technology
Industrial ROA for Real-World Labs
Our instrument adapts Raman Optical Activity (ROA) — historically confined to specialized research — into a practical, robust analytical method for industrial use. Developed at ETH Zurich, Enantios technology delivers direct structural and chiral sensitivity that is highly relevant to pharmaceutical and chemical applications.
Applications
Applications across the pharmaceutical and chemical lifecycle. Enantios ROA provides molecular insight that supports critical decisions wherever structure and chirality matter — from early discovery to manufacturing and quality investigations.
ABOUT US
Our Team
Dr. Carin Lightner
CEO Co-Founder
Dr. Roman Wyss
CTO Co-Founder
Dr. Monika Dengler
Head of Scientific Applications
Madeleine Marchand
Business Operations and People Lead
Dr. Norbert Modsching
Optics Engineer
Petra Hoffmann
Experimental Application Scientist
Support Organizations
